Who
Tim Watkins
CMO & Head of Development
Company insider
Files Form 4 as: CMO & Head of Development, Contineum Therapeutics.
In numbers
- Trades disclosed
- 27
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $602K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 28 Apr 2025
- Last trade
- 30 Jun 2026
- Last filed
- 1 Jul 2026
Companies traded
Activity over time
1 Dec 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jun 2026filed 1 Jul 2026 | CTNM Contineum TherapeuticsBiotechnology | SEC FORM 4 Code M | $49K10,833 at $4.50 | filing |
| 30 Jun 2026filed 1 Jul 2026 | CTNM Contineum TherapeuticsBiotechnology | SEC FORM 4 Sold | $174K10,833 at $16.02 | filing |
| 30 Jun 2026filed 1 Jul 2026 | CTNM Contineum Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,833 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | CTNM Contineum Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,833 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | CTNM Contineum TherapeuticsBiotechnology | SEC FORM 4 Code M | $49K10,833 at $4.50 | filing |
| 30 Jun 2026filed 1 Jul 2026 | CTNM Contineum TherapeuticsBiotechnology | SEC FORM 4 Sold | $174K10,833 at $16.02 | filing |
| 2 Mar 2026filed 2 Mar 2026 | CTNM Contineum TherapeuticsBiotechnology | SEC FORM 4 Code M | $16K3,611 at $4.50 | filing |
| 2 Mar 2026filed 2 Mar 2026 | CTNM Contineum TherapeuticsBiotechnology | SEC FORM 4 Sold | $54K3,611 at $15.02 | filing |
| 2 Mar 2026filed 2 Mar 2026 | CTNM Contineum Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,611 at $0.00 | filing |
| 2 Mar 2026filed 2 Mar 2026 | CTNM Contineum Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,611 at $0.00 | filing |
| 2 Mar 2026filed 2 Mar 2026 | CTNM Contineum TherapeuticsBiotechnology | SEC FORM 4 Code M | $16K3,611 at $4.50 | filing |
| 2 Mar 2026filed 2 Mar 2026 | CTNM Contineum TherapeuticsBiotechnology | SEC FORM 4 Sold | $54K3,611 at $15.02 | filing |
| 30 Jan 2026filed 30 Jan 2026 | CTNM Contineum Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 30 Jan 2026filed 30 Jan 2026 | CTNM Contineum Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 28 Jan 2026filed 30 Jan 2026 | CTNM Contineum TherapeuticsBiotechnology | SEC FORM 4 Code M | $16K3,611 at $4.50 | filing |
| 28 Jan 2026filed 30 Jan 2026 | CTNM Contineum TherapeuticsBiotechnology | SEC FORM 4 Sold | $39K2,800 at $14.09 | filing |
| 28 Jan 2026filed 30 Jan 2026 | CTNM Contineum TherapeuticsBiotechnology | SEC FORM 4 Sold | $12K811 at $14.48 | filing |
| 28 Jan 2026filed 30 Jan 2026 | CTNM Contineum Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,611 at $0.00 | filing |
| 28 Jan 2026filed 30 Jan 2026 | CTNM Contineum Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,611 at $0.00 | filing |
| 28 Jan 2026filed 30 Jan 2026 | CTNM Contineum TherapeuticsBiotechnology | SEC FORM 4 Code M | $16K3,611 at $4.50 | filing |
News
Contineum Therapeutics (NASDAQ:CTNM) Reaches New 1-Year Low – Time to Sell?CTNM · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Tim Watkins; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.